The versatile cancer drug Keytruda is now available as an injectable formula, thanks in part to research conducted aboard the International Space Station. According to NASA, Merck Research Labs has flown crystal growth experiments to the space station for over a decade to support its efforts to develop drug formulations that readily dissolve in liquid. The new injection takes about one minute every three weeks to administer, while intravenous Keytruda required at least 30 minutes every three weeks — a significant time savings that is also expected to reduce treatment costs.
Related Posts
Strep throat infections surge
Strep throat infection rates are higher than usual this year, and experts fear that surging cases may worsen an ongoing amoxicillin shortage, according to…
You can take control of your brain health
A study from the U.K. has some surprising results: You can do something to take care of your brain, and you can do it today. In the landmark study,…
Asthma Awareness Month Study: Nearly all patients make mistakes with inhalers
One half second is the difference between getting your whole inhaled dose of asthma medicine and just getting 20 percent, a new study has found. The study…